FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158037199> ?p ?o ?g. }

• W2158037199 endingPage "1238" @default.
• W2158037199 startingPage "1229" @default.
• W2158037199 abstract "Background An antipsychotic utilization pattern has evolved substantially over the past 20 years or so due to the introduction of the second-generation antipsychotics (SGAs) and the increasing understanding of their adverse effect profile. Objective To understand antipsychotic utilization trends (including monotherapy, antipsychotic switching, and combination therapy) and to investigate factors associated with antipsychotic index medication selection (SGAs vs first-generation antipsychotics [FGAs]) among Texas veterans. Methods Data were taken from the Veterans Administration North Texas Health Care System (VANTHCS) and South Texas Veterans Health Care System (STVHCS) from January 1996 to December 2003. Adults with continuous enrollment (1 y before and after the Index date) who had newly initiated antipsychotic therapy were included. Prescriptions were followed for up to 12 months. Descriptive analyses examined utilization trends; logistic regression evaluated factors associated with antipsychotic index medication selection. Results: A total of 8096 patients were included in the study (VANTHCS n = 4477; STVHCS n = 3619), with the majority being male (93.6%) and white (62.6%) and nearly naif aged 55 years or older (44.1%). Between 1997 and 2002, antipsychotic prescriptions changed from primarily FGAs (1997:71.7%; 1999; 25.2%; 2002: 5.7%) to SGAs. Over the 6-year time frame, risperidone (31.0%) and olanzapine (30.7%) were most commonly prescribed. The overall combination therapy slightly increased over time (4.3%), switching to another antipsychotic remained stable (14.2%), and antipsychotic monotherapy remained dominant (81.5%). Hispanic and black patients were less likely than white patients to be initiated on SGAs. Patients who were older, had hypertension, and were in STVHCS were less likely to start on SGAs. Patients with dyslipidemia, bipolar disorder, and treatment in recent years were more likely to start on SGAs Conclusions: SGAs have replaced FGAs as first-line medications for patients with mental disorders. Race, age, physical comorbidities (ie, dyslipidemia, hypertension), and treatment initiation year were important factors in index medication selection." @default.
• W2158037199 created "2016-06-24" @default.
• W2158037199 creator A5026604545 @default.
• W2158037199 creator A5037714580 @default.
• W2158037199 creator A5039235704 @default.
• W2158037199 creator A5048048934 @default.
• W2158037199 creator A5049953443 @default.
• W2158037199 creator A5061941277 @default.
• W2158037199 creator A5076279533 @default.
• W2158037199 creator A5084715432 @default.
• W2158037199 date "2008-07-29" @default.
• W2158037199 modified "2023-09-27" @default.
• W2158037199 title "Antipsychotic Medication Utilization Trends Among Texas Veterans: 1997–2002" @default.
• W2158037199 cites W1606742910 @default.
• W2158037199 cites W1870664623 @default.
• W2158037199 cites W1970005786 @default.
• W2158037199 cites W1976901622 @default.
• W2158037199 cites W1981186498 @default.
• W2158037199 cites W1982539986 @default.
• W2158037199 cites W1985731915 @default.
• W2158037199 cites W2002703519 @default.
• W2158037199 cites W2006050379 @default.
• W2158037199 cites W2012879472 @default.
• W2158037199 cites W2022765281 @default.
• W2158037199 cites W2029754105 @default.
• W2158037199 cites W2041474698 @default.
• W2158037199 cites W2051913696 @default.
• W2158037199 cites W2063645217 @default.
• W2158037199 cites W2067793211 @default.
• W2158037199 cites W2074171524 @default.
• W2158037199 cites W2078195425 @default.
• W2158037199 cites W2083143542 @default.
• W2158037199 cites W2088025346 @default.
• W2158037199 cites W2089051089 @default.
• W2158037199 cites W2105918612 @default.
• W2158037199 cites W2109481947 @default.
• W2158037199 cites W2126410482 @default.
• W2158037199 cites W2128825342 @default.
• W2158037199 cites W2130535790 @default.
• W2158037199 cites W2134399699 @default.
• W2158037199 cites W2136962131 @default.
• W2158037199 cites W2142215664 @default.
• W2158037199 cites W2151893425 @default.
• W2158037199 cites W2157130535 @default.
• W2158037199 cites W2159155203 @default.
• W2158037199 cites W2170792659 @default.
• W2158037199 cites W2912016724 @default.
• W2158037199 cites W2916678927 @default.
• W2158037199 cites W4241549010 @default.
• W2158037199 cites W58391041 @default.
• W2158037199 cites W91709844 @default.
• W2158037199 doi "https://doi.org/10.1345/aph.1l155" @default.
• W2158037199 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18682544" @default.
• W2158037199 hasPublicationYear "2008" @default.
• W2158037199 type Work @default.
• W2158037199 sameAs 2158037199 @default.
• W2158037199 citedByCount "25" @default.
• W2158037199 countsByYear W21580371992012 @default.
• W2158037199 countsByYear W21580371992013 @default.
• W2158037199 countsByYear W21580371992014 @default.
• W2158037199 countsByYear W21580371992015 @default.
• W2158037199 countsByYear W21580371992016 @default.
• W2158037199 countsByYear W21580371992018 @default.
• W2158037199 countsByYear W21580371992020 @default.
• W2158037199 countsByYear W21580371992021 @default.
• W2158037199 countsByYear W21580371992023 @default.
• W2158037199 crossrefType "journal-article" @default.
• W2158037199 hasAuthorship W2158037199A5026604545 @default.
• W2158037199 hasAuthorship W2158037199A5037714580 @default.
• W2158037199 hasAuthorship W2158037199A5039235704 @default.
• W2158037199 hasAuthorship W2158037199A5048048934 @default.
• W2158037199 hasAuthorship W2158037199A5049953443 @default.
• W2158037199 hasAuthorship W2158037199A5061941277 @default.
• W2158037199 hasAuthorship W2158037199A5076279533 @default.
• W2158037199 hasAuthorship W2158037199A5084715432 @default.
• W2158037199 hasConcept C118552586 @default.
• W2158037199 hasConcept C126322002 @default.
• W2158037199 hasConcept C151956035 @default.
• W2158037199 hasConcept C2426938 @default.
• W2158037199 hasConcept C2776412080 @default.
• W2158037199 hasConcept C2776619155 @default.
• W2158037199 hasConcept C2780057945 @default.
• W2158037199 hasConcept C2780494398 @default.
• W2158037199 hasConcept C71924100 @default.
• W2158037199 hasConcept C98274493 @default.
• W2158037199 hasConceptScore W2158037199C118552586 @default.
• W2158037199 hasConceptScore W2158037199C126322002 @default.
• W2158037199 hasConceptScore W2158037199C151956035 @default.
• W2158037199 hasConceptScore W2158037199C2426938 @default.
• W2158037199 hasConceptScore W2158037199C2776412080 @default.
• W2158037199 hasConceptScore W2158037199C2776619155 @default.
• W2158037199 hasConceptScore W2158037199C2780057945 @default.
• W2158037199 hasConceptScore W2158037199C2780494398 @default.
• W2158037199 hasConceptScore W2158037199C71924100 @default.
• W2158037199 hasConceptScore W2158037199C98274493 @default.
• W2158037199 hasIssue "9" @default.
• W2158037199 hasLocation W21580371991 @default.
• W2158037199 hasLocation W21580371992 @default.

• next